UC, Berkeley files brief in CRISPR Federal Circuit case
31-07-2017
EPO to grant UC, Berkeley CRISPR patent
28-03-2017
designer491 / iStockphoto.com
Excision BioTherapeutics has become the first company to secure exclusive licences from the University of California (UC), Berkeley for “newly discovered” CRISPR gene editors.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Excision BioTherapeutics, gene-editing, viruses, CRISPR, Jennifer Doudna, licence, UC, Berkeley, DNA
